U.S., Liberia kick off trial of Ebola drug ZMapp

World / Science & Health Mar 2, 2015

U.S., Liberia kick off trial of Ebola drug ZMapp

U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc.'s Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries. The trial, a joint effort ...

Experimental Ebola drugs needed for 'up to 30,000 people'

World / Science & Health Aug 21, 2014

Experimental Ebola drugs needed for 'up to 30,000 people'

Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday. The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of unproven ...